AlenMed

Treatment in Germany

EN

Mon–Fri 9:00–21:00 · Sat 10:00–18:00 (CET)
+49 176 61975550 — daily until 23:00

Bladder Cancer Diagnosis in Germany

Updated

Bladder cancer diagnosis in Germany is a sequence of steps: urine tests, ultrasound, a camera look inside the bladder and, if needed, removal of the growth for examination under a microscope. The usual trigger is painless blood in the urine. Its cause may be harmless or a tumour, so the answer comes from a sequence of tests, not from guesswork.

This page explains each step from the first suspicion to staging, and why it is needed. It covers diagnosis only; what happens next is described on the page on bladder cancer treatment in Germany.

When a Urologist Looks for a Bladder Tumour

A urologist looks for a tumour when there are signs it can cause: visible blood in the urine, red cells in a urine test, frequent painful urination without infection, or “cystitis” that keeps coming back. Blood may colour the urine red or brown and then vanish, which is no reason to delay a visit.

Some factors make the doctor more alert: smoking, work with aromatic amines and dyes, and previous radiotherapy to the pelvis. None of them means the disease is present; they are simply a reason not to delay tests once symptoms appear.

First Tests: Urine, Cytology and Ultrasound

The first tests are urinalysis and culture, cytology and ultrasound, none of which involves any intervention. The first two rule out infection, which causes similar complaints and can distort cytology. Cytology means looking under the microscope for cells that a tumour sheds into the urine. It detects aggressive tumours well, but the cells of small, less aggressive tumours resemble healthy ones and may be scarce, so a negative result does not remove the suspicion.

Ultrasound of the bladder and kidneys is the first painless look: the doctor checks for urine backing up into the kidneys, for stones or a growth. Small flat lesions may not be seen, so a normal scan does not replace cystoscopy if the suspicion remains.

Cystoscopy and TURBT: How the Diagnosis Is Confirmed

The diagnosis is confirmed by looking inside the bladder and examining removed tissue. Cystoscopy uses a thin, flexible endoscope with a camera, passed through the urethra. It is an outpatient procedure under local anaesthetic: a numbing gel is applied to the urethra first. It can feel unpleasant but is rarely painful; the examination itself takes only a few minutes, the preparation longer.

In fluorescence (blue-light) cystoscopy, also called photodynamic diagnosis, a solution of hexaminolevulinate is placed in the bladder beforehand; under blue light it makes tumour tissue glow, so flat lesions are easier to see. It is not used in every case, only for a specific reason, such as a suspected flat lesion when tumour cells have been found in the urine.

TURBT (transurethral resection of a bladder tumour) is both diagnosis and the first step of treatment. Under anaesthesia, the tumour is removed through the endoscope with an electric loop, together with some of the muscle beneath it, the detrusor. The pathologist then determines the tumour’s type and depth. The key question is whether the muscle layer is involved, because everything that follows depends on it, including whether immunotherapy for bladder cancer is needed. The German S3 guideline on bladder cancer sets out this sequence.

Staging: CT, MRI and the Extent of the Disease

The stage is clarified with imaging, chosen according to how deep the tumour has grown. CT urography, with contrast that is excreted in the urine, shows the kidneys and the upper urinary tract. If the tumour is invasive, meaning it has reached the muscle, a CT of the chest and abdomen shows the lymph nodes and any distant spread.

MRI of the pelvis helps judge how deep the tumour has grown into the bladder wall; it is read on a dedicated scale, VI-RADS, and can be done before the resection. The urologist decides which method is needed after TURBT: if a superficial tumour has been removed completely, whole-body staging may be unnecessary. Good-quality recent images from home are not repeated without reason. How cancer diagnosis in Germany works in general is explained separately.

Frequently asked questions

The blood in my urine went away. Do I still need tests?

Yes, see a urologist even if the blood appeared only once. With a bladder tumour, bleeding often comes and goes, so its disappearance proves nothing. The cause is often harmless, such as an infection, stones or an enlarged prostate, but only tests can tell, and they start with a urine test and ultrasound.

Is cystoscopy painful?

Usually not: it can be unpleasant but is rarely painful. A numbing gel is applied to the urethra, and a thin flexible endoscope is easier to tolerate than a rigid one. Local anaesthetic is usually enough, but anxious patients can also have a mild sedative; in that case they should not drive afterwards.

Can cystoscopy be skipped if the ultrasound and urine tests are normal?

No, not while the suspicion remains: cystoscopy is the standard examination. Ultrasound may miss a flat lesion, and cytology a small, less aggressive tumour. Pelvic MRI helps judge depth but does not replace a look inside the bladder, and only tissue examined under a microscope gives the final answer.

How long do the tests take?

Several days, sometimes weeks, depending on what each step shows. Urine tests, ultrasound and cystoscopy are outpatient procedures; TURBT needs anaesthesia, followed by the pathologist’s report. If CT or MRI is needed after that, the scans add time. Complete, good-quality results from home help avoid starting from scratch.

How AlenMed Arranges Bladder Cancer Diagnosis in Germany

AlenMed starts with your documents, which show the urologist in Germany what is still needed. Please send urine results, ultrasound, the urologist’s report and images on disc and, if surgery has already been done, the histology slides and blocks. We translate them and send them to a urology department experienced in uro-oncology. If you were diagnosed at home, the same documents are the basis for a second opinion in Germany.

Partner hospitals include the Urology Clinic Munich-Planegg, where Professor Maximilian Kriegmair, formerly head of the bladder cancer centre in Mannheim, is one of the clinic directors. At Klinikum rechts der Isar of the Technical University of Munich, the urology department is led by Professor Jürgen Gschwend, head of its bladder cancer centre. The hospital is chosen for the case, not for the name. The company office in Munich coordinates dates, interpreter and accommodation.

This material is for reference only and is not an offer. The scope of tests and the treatment plan are decided by the doctor at a face-to-face consultation.